Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review
Year: 2022
Type: review
Study design: Systematic Review
Institutions: Brigham and Women's Hospital, Harvard University, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Boston Children's Hospital, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, National Guard Health Affairs, Dana-Farber/Harvard Cancer Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G4357363684
OpenAlex ID: W4310713879
